Revvity, Inc.
RVTY
$2.17 (-2.27%)
1D
1W
3M
1Y
5Y
ALL
Revvity, Inc. is a provider of health science solutions, technologies, and services, which delivers workflows from discovery to development, and diagnosis to cure. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. It offers instruments, reagents, assay platforms and software to hospitals, and medical labs. It is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 23 days ago • RVTY
RVTY Stock Falls Despite the Latest Launch of Automated InstrumentSeeking Alpha • about a month ago • RVTY
Revvity: Despite Facing Multiple Headwinds, Shares Are A BuyZacks Investment Research • about 2 months ago • RVTY
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View UpSeeking Alpha • about 2 months ago • RVTY
Revvity, Inc. (RVTY) Q1 2025 Earnings Call TranscriptZacks Investment Research • about 2 months ago • RVTY
Revvity (RVTY) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.